Search
for
Sort by
Research 121–150 of 254
- Skin manifestations after bariatric surgery
- Malignant epithelial tumors: Part II. Therapy and prevention
- New therapies for alopecia areata
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Dermatologists’ Role in Interdisciplinary Care for Obsessive-Compulsive Disorder and Body-Focused Repetitive Behaviors
- PATTERN OF CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
- Skin Disorders in Athletes: Professional and Recreational Sports
- Registrars’ Symposium: Summaries of Papers
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Digital Pseudopad Correction in a Dog Using a CO <sub>2</sub> Laser
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- The role of platelet-rich plasma in biomedicine: A comprehensive overview
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Case Report of Wound Treatment with Hyiodine Gel in an Occasional KID Syndrome Patient
- Immunology of the Human Nail Apparatus: The Nail Matrix Is a Site of Relative Immune Privilege
- Epidermal growth factor receptor inhibitors and hair
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- SARGRAMOSTIN
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Management of Dermatologic Toxicities
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Atypical presentation of Acrodermatitis enteropathica in a child: later onset with life-threatening severe extensive dermatitis and septic shock